Clinical Trial Update: A Study Evaluating the Efficacy and Safety of MEGF0444A Dosed to Progression in Combination With Bevacizumab and mFOLFOX-6 in Participants With Previously Untreated Metastatic Colorectal Cancer [Phase 2]

View source ↗

Summary

A Phase 2 study completed to evaluate the efficacy and safety of MEGF0444A in combination with bevacizumab and mFOLFOX-6 in previously untreated metastatic colo…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• 5-Fluorouracil (5-FU)
• Bevacizumab (bevacizumab)
• Leucovorin (folinic acid)
• MEGF0444A
• OXALIPLATIN (Oxaliplatin)

Snippet

Sponsor: Genentech, Inc. | Conditions: Metastatic Colorectal Cancer | Phase 2 | Status: COMPLETED